Aarti Pharmalabs Limited (BOM:543748)

Market Cap	78.41B
Revenue (ttm)	19.01B
Net Income (ttm)	2.40B
Shares Out	n/a
EPS (ttm)	26.44
PE Ratio	32.70
Forward PE	n/a
Dividend	5.00 (0.59%)
Ex-Dividend Date	Sep 15, 2025

Volume	3,200
Average Volume	7,254
Open	844.95
Previous Close	843.00
Day's Range	836.75 - 869.55
52-Week Range	550.25 - 971.50
Beta	n/a
RSI	56.37
Earnings Date	Oct 28, 2025

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,162
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In 2024, Aarti Pharmalabs's revenue was 21.15 billion, an increase of 14.17% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.